Efficacy of antibiotics against influenza-like illness in an influenza epidemic

Pediatrics International

Volumn 41, Issue 3, 1999, Pages 274-276

  Maeda, Sachiko ^a   Yamada, Yoshiyasu ^a   Nakamura, Hajime ^b   Maeda, Taro ^a  

^a Konan Hospital Foundation Rokko Island Hospital   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Influenza; Influenza virus; Pneumonia; Protease; Sultamicillin

Indexed keywords

SULTAMICILLIN;

ANTIBIOTIC THERAPY; ARTICLE; CHILD; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; EPIDEMIC; FEMALE; FEVER; HUMAN; INFANT; INFLUENZA; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; OTITIS MEDIA; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; TREATMENT OUTCOME;

ACUTE DISEASE; AMPICILLIN; BACTERIAL INFECTIONS; CHILD, PRESCHOOL; DIARRHEA; DISEASE OUTBREAKS; DRUG THERAPY, COMBINATION; FEMALE; FEVER; HUMANS; INCIDENCE; INFLUENZA A VIRUS; INFLUENZA, HUMAN; JAPAN; MALE; OTITIS MEDIA; PNEUMONIA, BACTERIAL; POPULATION SURVEILLANCE; SULBACTAM; URBAN HEALTH;

EID: 0032976699     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200x.1999.01069.x     Document Type: Article

References (11)

1. 1 Nichol KL, Margolis KL, Wuorenmia J, Von Sterberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N. Engl. J. Med. 1994; 331: 778-84.
2. 2 Govaert TME, Thijs CTMCN, Masurel N, Sprenger MJW, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994; 272: 1661-5.
3. 3 Smorodintsev AA, Zlydnikov DM, Kiseleva AM, Romanov JA, Kazantsev AP, Rumovsky VI. Evaluation of amantadine in artificially induced A2 and B influenza. JAMA 1970; 213: 1448-54.
4. 4 Oker-Blom N, Hovi T, Leinikki P, Palosuo T, Petterson R, Suni J. Protection of man from natural infection with influenza A2 Hong Kong virus by amantadine: A controlled field trial. BMJ 1970; 3: 679-8.
5. 5 Dolin R, Reichman RC, Madore HP, Maynard R, Linton PN, Webber JJ. A controlled trial of amantadine and rimantadin in the prophylaxis of influenza A infection. N. Engl. J. Med. 1982; 307: 580-4.
6. 6 Wiselka M. Education and debate. Influenza: diagnosis, management and prophylaxis. BMJ 1994; 308: 1341-5.
7. 7 Zhirnov OP, Ovcharenko AV, Bukrinskaya AG. Suppression of influenza virus replication in infected mice by protease inhibitors. J. Gen. Virol. 1984; 65: 191-6.
8. 8 Tashiro M, Rott R. The role of proteolytic cleavage of viral glycoproteins in the pathogenesis of influenza virus infections. Semin. Virol. 1996; 7: 237-43.
9. 9 Scheiblauer H, Reinacher M, Tashiro M, Rott R. Interactions between bacteria and influenza A virus in the development of influenza pneumonia. J. Infect. Dis. 1992; 166: 783-91.
10. 10 Reye RDK, Morgan G, Baral J. Encephalopathy and fatty degeneration of the viscera; a disease entity in childhood. Lancet 1963; i: 749-52.
11. 11 Oseasohn R, Adelson L, Kaji M. Clinicopathological study of thirty-three fatal cases of Asian influenza. N. Engl. J. Med. 1959; 260: 509-18.